Syntellix Asia Pte. Ltd. was founded in May 2017 in Singapore in order to become the first international subsidiary of Syntellix AG, an internationally operating, dynamically growing medical technology company that specializes in the research, development, marketing and sales of highly innovative bioabsorbable metallic implants. Syntellix has succeeded in producing a globally unique medical innovation with MAGNEZIX® – the world's first magnesium-based material for metallically stable and simultaneously degradable implants. MAGNEZIX® implants degrade in the body and are converted into endogenous bone tissue whilst providing a unique and highly favorable combination of stability, elasticity and bioabsorbability, and therefore save patients the stress and the worry of having to undergo a second surgery to remove the implant.
Syntellix Asia serves as the regional headquarter for the booming Asian healthcare market. Specialized in MAGNEZIX® manufacturing, Syntellix Asia’s technical area has established a state-of-the-art production process for highest quality, magnesium-based orthopedic implants. In addition, Syntellix Asia goes beyond being an important distribution hub, working with local institutions to develop more holistic approaches to improving clinical outcomes for surgeons and patients.
Numerous highly prestigious international prizes and awards underline the globally unique innovative potential of MAGNEZIX® as a new benchmark for implants. These include the Innovation Award of the German Economy 2012/13, the Future Award 2016 of the German Healthcare Economy, the German Medical Award 2017, the STEP Award 2017 and the Innovator of the Year 2017 Award – and very recently in 2019 the German Innovation Award in Gold. MAGNEZIX® implants were also a winner in the Product of the Year category of the Sustainability Award 2018 program.
Learn more about the history of Syntellix AG here.
Manufacturing site in Tuas.
Courtesy by JTC.
Commercial office in Science Park Drive.
Courtesy by Ascendas.